TG THERAPEUTICS, INC. Construction Contract Cost, Progress Payment Offset
TG THERAPEUTICS, INC. (TGTX) had Construction Contract Cost, Progress Payment Offset of $37.40 million as of 2020-12-31, per its 10-K filed 2021-03-01.
Discontinued › Notes
us-gaap:ConstructionContractCostProgressPaymentOffset · last filed 2021-03-01
- 2020-12-31: Construction Contract Cost, Progress Payment Offset $37.40M.
- 2020-09-30: Construction Contract Cost, Progress Payment Offset $33.20M.
- 2020-06-30: Construction Contract Cost, Progress Payment Offset $27.00M.
- 2020-03-31: Construction Contract Cost, Progress Payment Offset $20.30M.
| Period end | Construction Contract Cost, Progress Payment Offset |
|---|---|
| 2020-12-31 | $37.40M 10-K · filed 2021-03-01 |
| 2020-09-30 | $33.20M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $27.00M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $20.30M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $0.00 10-K · filed 2020-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |